These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 28273828)

  • 1. Association of Serum Manganese Levels with  Alzheimer's Disease and Mild Cognitive Impairment:  A Systematic Review and Meta-Analysis.
    Du K; Liu M; Pan Y; Zhong X; Wei M
    Nutrients; 2017 Mar; 9(3):. PubMed ID: 28273828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum TC and LDL-C levels in Alzheimer's disease and mild cognitive impairment: A meta-analysis study.
    Liu Y; Zhong X; Shen J; Jiao L; Tong J; Zhao W; Du K; Gong S; Liu M; Wei M
    Brain Res; 2020 Jan; 1727():146554. PubMed ID: 31765631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis.
    Ng TKS; Ho CSH; Tam WWS; Kua EH; Ho RC
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the diagnostic value of peripheral BDNF levels for Alzheimer's disease and mild cognitive impairment: results of a meta-analysis.
    Xie B; Zhou H; Liu W; Yu W; Liu Z; Jiang L; Zhang R; Cui D; Shi Z; Xu S
    Int J Neurosci; 2020 Mar; 130(3):218-230. PubMed ID: 31518516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lead and manganese levels in serum and erythrocytes in Alzheimer's disease and mild cognitive impairment: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing.
    Hare DJ; Faux NG; Roberts BR; Volitakis I; Martins RN; Bush AI
    Metallomics; 2016 Jun; 8(6):628-32. PubMed ID: 26962965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer's disease: a meta-analysis study (N=7277).
    Qin XY; Cao C; Cawley NX; Liu TT; Yuan J; Loh YP; Cheng Y
    Mol Psychiatry; 2017 Feb; 22(2):312-320. PubMed ID: 27113997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Homocysteine and Serum Folate and Vitamin B
    Ma F; Wu T; Zhao J; Ji L; Song A; Zhang M; Huang G
    Nutrients; 2017 Jul; 9(7):. PubMed ID: 28698453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
    Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
    Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of circulating manganese levels with Parkinson's disease: A meta-analysis.
    Du K; Liu MY; Pan YZ; Zhong X; Wei MJ
    Neurosci Lett; 2018 Feb; 665():92-98. PubMed ID: 29191695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower Serum Calcium as a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer's Disease in the Japanese Alzheimer's Disease Neuroimaging Initiative.
    Sato K; Mano T; Ihara R; Suzuki K; Tomita N; Arai H; Ishii K; Senda M; Ito K; Ikeuchi T; Kuwano R; Matsuda H; Iwatsubo T; Toda T; Iwata A;
    J Alzheimers Dis; 2019; 68(2):777-788. PubMed ID: 30814351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis.
    Kim BY; Lee SH; Graham PL; Angelucci F; Lucia A; Pareja-Galeano H; Leyhe T; Turana Y; Lee IR; Yoon JH; Shin JI
    Mol Neurobiol; 2017 Nov; 54(9):7297-7311. PubMed ID: 27815832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors of Rapid Cognitive Decline in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.
    Song YN; Wang P; Xu W; Li JQ; Cao XP; Yu JT; Tan L
    J Alzheimers Dis; 2018; 66(2):497-515. PubMed ID: 30320579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary fatty acids and risk for Alzheimer's disease, dementia, and mild cognitive impairment: A prospective cohort meta-analysis.
    Zhu RZ; Chen MQ; Zhang ZW; Wu TY; Zhao WH
    Nutrition; 2021 Oct; 90():111355. PubMed ID: 34218119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis.
    Parnetti L; Chipi E; Salvadori N; D'Andrea K; Eusebi P
    Alzheimers Res Ther; 2019 Jan; 11(1):7. PubMed ID: 30646955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum haptoglobin in Chinese patients with Alzheimer's disease and mild cognitive impairment: A case-control study.
    Zhu CJ; Jiang GX; Chen JM; Zhou ZM; Cheng Q
    Brain Res Bull; 2018 Mar; 137():301-305. PubMed ID: 29325993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional status and body composition by bioelectrical impedance vector analysis: A cross sectional study in mild cognitive impairment and Alzheimer's disease.
    Cova I; Pomati S; Maggiore L; Forcella M; Cucumo V; Ghiretti R; Grande G; Muzio F; Mariani C
    PLoS One; 2017; 12(2):e0171331. PubMed ID: 28187148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum tumour necrosis factor-α and interleukin-6 levels in Alzheimer's disease and mild cognitive impairment.
    Kim YS; Lee KJ; Kim H
    Psychogeriatrics; 2017 Jul; 17(4):224-230. PubMed ID: 28130814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood fatty acids in Alzheimer's disease and mild cognitive impairment: A meta-analysis and systematic review.
    Hosseini M; Poljak A; Braidy N; Crawford J; Sachdev P
    Ageing Res Rev; 2020 Jul; 60():101043. PubMed ID: 32194194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.